BRAIN Biotech AG
XETRA:BNN
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
DE |
BRAIN Biotech AG
XETRA:BNN
|
61.2m EUR | 2 | ||
JP |
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 10.9 | ||
US |
Sherwin-Williams Co
NYSE:SHW
|
77.1B USD | 7.9 | ||
US |
Ecolab Inc
NYSE:ECL
|
64.3B USD | 11.1 | ||
CH |
Sika AG
SIX:SIKA
|
42.2B CHF | 7.7 | ||
CH |
Givaudan SA
SIX:GIVN
|
36.6B CHF | 14.2 | ||
CN |
Wanhua Chemical Group Co Ltd
SSE:600309
|
279.8B CNY | 12.9 | ||
US |
Dupont De Nemours Inc
NYSE:DD
|
33.7B USD | 9.2 | ||
IN |
Asian Paints Ltd
NSE:ASIANPAINT
|
2.9T INR | 18.1 | ||
US |
PPG Industries Inc
NYSE:PPG
|
30.7B USD | 4.7 | ||
CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.1B EUR | 11 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.